Reverse takotsubo cardiomyopathy is a rare heart failure condition characterized by systolic dysfunction of the basal segments of the left ventricle in the absence of obstructive coronary artery disease. We present a case of a 54-year-old man with an overdose of Extenze (a male enhancer pill containing yohimbine) who was hospitalized with heart failure due to reverse takotsubo cardiomyopathy.
T he pathogenesis of reverse takotsubo cardiomyopathy is not well understood, but physical or mental stress is frequently an associated trigger. Less commonly reported, sympathomimeti c states have been linked to this disease entity. Reverse takotsubo cardiomyopathy has been reported in cases of hyperadrenergic states secondary to pheochromocytomas, catecholamine-secreting tumors, administration of beta-receptor agonists, such as dobutamine, and consumption of caff eine and energy drinks. In this report, we describe a case of reverse takotsubo cardiomyopathy relating to an overdose of Extenze, a male enhancer pill containing yohimbine.
CASE PRESENTATION
A 54-year-old man was admitted to the intensive care unit after ingesting multiple pills of Tylenol and Extenze, a product that contains yohimbine. He complained of abdominal discomfort and mild dyspnea. He was anxious and had a heart rate of 110 beats/minute. Th e electrocardiogram showed sinus tachycardia, right bundle branch block, and ST segment depression in lead V3 (Figure 1) . A radiograph showed pulmonary congestion (Figure 2 ). His initial troponin I level was 0.94 ng/L; 7 hours later, it was 13 ng/L. Th ree hours after admission, he became disoriented, hypotensive, and hypoxic and was intubated for respiratory distress due to heart failure. An echocardiogram showed left ventricular systolic dysfunction with basal hypokinesis but normal mid/distal anterior, inferior, and apical contraction ( Figure 3 ). Coronary angiography was normal without any anatomical or functional abnormalities such as coronary spasm, myocardial bridging, or coronary artery disease ( Figure  4 ). Since the patient had an echocardiogram showing reverse takotsubo cardiomyopathy with severely depressed LV systolic function on the same day prior to cardiac catheterization, no ventriculogram was performed. Th e patient was treated with vasopressors, diuretics, and invasive ventilatory support. After 72 hours, the patient was extubated and transferred to a regular fl oor. He recovered fully and was discharged after 1 week of hospitalization. Unfortunately, the patient did not follow up in the cardiology clinic; thus, no follow-up echocardiogram was performed.
DISCUSSION
Takotsubo cardiomyopathy is an increasingly reported syndrome characterized by transient systolic dysfunction of the apical and or mid segments of the left ventricle without the presence of coronary artery disease (1, 2). In contrast, reverse takotsubo cardiomyopathy is a condition with transient systolic dysfunction of the basal segments of the left ventricle. Although transient, reverse, or inverted takotsubo cardiomyopathy was recognized as a diff erent clinical entity >20 years ago, a defi nite comprehensive pathophysiologic theory for this condition is still lacking (3). Seemingly, reverse takotsubo, which is more common in young female patients with a mean age of 36 years, is thought to be triggered by physical or emotional stress rather than catecholaminergic states. Th e presence of adrenoreceptors, which are at their apex in older patients, makes the occurrence of the apical variant of takotsubo cardiomyopathy more common among the older population, in contrast to the younger population, where the abundance of adrenoreceptors is within the base of the heart, which may lead to the reverse variant of takotsubo cardiomyopathy (4). Th ere have been documented reports of reverse takotsubo in association with pheochromocytomas, intravenous administration of beta-receptor agonists (dobutamine) or catecholamines, as well as with the use of energy drinks containing caff eine and 1,3-dimethylamylamine (5) .
Th e pathophysiology behind this condition relies on two primary theories: vascular dysfunction and catecholamineinduced toxicity. Multifocal vasospasm has been demonstrated Reverse takotsubo cardiomyopathy with use of male enhancers Carlos E. Rodriguez-Castro, MD, Fatima Saifuddin, MD, Mateo Porres-Aguilar, MD, Sarmad Said, MD, David Gough, MD, Tariq Siddiqui, MD, Debabrata Mukherjee, MD, and Aamer Abbas, MD tremors, and diaphoresis (8, 9) . In addition, yohimbine-containing products have been implicated in cases of hypertension emergencies, severe Raynaud's phenomenon, angina pectoris, refractory priapism, and even death (10) (11) (12) (13) (14) . Currently, the association of reverse takotsubo cardiomyopathy and yohimbine is not known. Nonetheless, we think that, given the mechanism of action of yohimbine as a sympathomimetic drug acting on in some patients undergoing angiography (6) . Molecular studies have revealed that high doses of epinephrine are directly toxic to the cells, causing a rise in adenosine 3',5'-cyclic monophosphate and calcium levels that then trigger the formation of free oxygen radicals, the initiation of expression of stress response genes, and induction of apoptosis (7).
Th e yohimbine contained in the male enhancement formula Extenze is a competitive antagonist that is selective for alpha-2 receptors located in the central nervous system, where it acts to increase blood pressure and heart rate. It has been well acknowledged that with relatively low doses it can produce side effects such as tachycardia, chest pain, hypertension, lacrimation, the alpha-2 adrenergic receptors, overdose potentially infl uenced the development of re verse takotsubo cardiomyopathy similar to cases related to pheochromocytomas and administration of dobutamine.
